CVAC

CureVac N.V.

3.42 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

CureVac N.V. stock is down -2.56% since 30 days ago. The next earnings date is Apr 25, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 March’s closed higher than February. In the last 4 Unusual Options Trades, there were 4 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
11 Jan 15:16 19 Jan, 2024 12.50 PUT 41 45
12 Jan 20:31 19 Jul, 2024 10.00 PUT 41 60
17 Jan 18:14 19 Jan, 2024 5.00 PUT 221 666
17 Jan 18:15 19 Jan, 2024 5.00 PUT 200 666

About CureVac N.V.

CureVac N.V. focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA) It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV and CV7202. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma.